|
RBM45 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.35399999999731E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.788500E-04 |
| Normal-vs-Stage2 |
1.738670E-03 |
| Normal-vs-Stage3 |
4.08250000000221E-05 |
| Normal-vs-Stage4 |
1.357350E-04 |
| Stage1-vs-Stage2 |
5.791000E-01 |
| Stage1-vs-Stage3 |
8.849900E-02 |
| Stage1-vs-Stage4 |
2.089400E-01 |
| Stage2-vs-Stage3 |
5.242800E-01 |
| Stage2-vs-Stage4 |
5.854600E-01 |
| Stage3-vs-Stage4 |
9.499800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47329999999435E-05 |
| Normal-vs-AfricanAmerican |
1.000350E-01 |
| Normal-vs-Asian |
1.000170E-02 |
| Caucasian-vs-AfricanAmerican |
2.255000E-01 |
| Caucasian-vs-Asian |
3.772000E-01 |
| AfricanAmerican-vs-Asian |
6.185400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.66380000000377E-05 |
| Normal-vs-Female |
1.596950E-04 |
| Male-vs-Female |
4.682000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.630200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.625100E-04 |
| Normal-vs-Age(61-80Yrs) |
8.47040000000465E-05 |
| Normal-vs-Age(81-100Yrs) |
5.609800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.022600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.273400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.496800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.458400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.890200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.074800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.540420E-01 |
| Classical-VS-Follicular |
8.534000E-01 |
| Classical-VS-Other |
2.222200E-01 |
| Classical-VS-Normal |
1.964050E-04 |
| Tall-VS-Follicular |
2.987800E-01 |
| Tall-VS-Other |
6.566200E-01 |
| Tall-VS-Normal |
3.404900E-04 |
| Follicular-VS-Other |
4.121200E-01 |
| Follicular-VS-Normal |
3.561000E-03 |
| Other-VS-Normal |
9.780000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.404500E-04 |
| Normal-vs-N1 |
4.11350000000255E-05 |
| N0-vs-N1 |
1.656960E-01 |
|
|
